Gain Therapeutics, Inc. (GANX)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-108.6%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | $55.2K | $140.1K | $165.0K | $28.9K | — |
| Operating Income | -$18.71M | -$20.35M | -$22.25M | -$17.78M | -$13.83M | -$3.48M | — |
| Net Income | -$20.16M | -$20.41M | -$22.27M | -$17.59M | -$13.89M | -$3.58M | — |
| EPS (Diluted) | $-0.61 | $-0.89 | $-1.71 | $-1.48 | $-1.37 | $-1.33 | — |
| Total Assets | $22.82M | $12.12M | $18.61M | $24.10M | $38.99M | $9.60M | — |
| Total Liabilities | $4.25M | $4.78M | $6.03M | $5.22M | $4.17M | $3.40M | — |
| Shareholders' Equity | $18.56M | $7.34M | $12.58M | $18.88M | $34.82M | $6.20M | -$449.9K |
| Cash & Equivalents | $20.84M | $10.39M | $11.79M | $7.31M | $36.88M | $7.49M | — |
| Operating Cash Flow | -$18.47M | -$18.87M | -$18.87M | -$14.69M | -$12.37M | -$3.24M | — |
| Capital Expenditures | — | $22.5K | $15.4K | $119.0K | $94.2K | — | — |
| Shares Outstanding | 42.07M | 27.13M | 16.21M | 11.88M | 11.88M | 3.54M | — |